Identifying disease modifying genes in multiple sclerosis

被引:100
|
作者
Kantarci, OH
de Andrade, M
Weinshenker, BG
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
multiple sclerosis; genetics; prognosis; severity; course; outcome;
D O I
10.1016/S0165-5728(01)00481-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evidence is mounting that genetic variation influences not only susceptibility to multiple sclerosis (MS), but also its course and severity. Identification of disease modifying genes, however, poses unique challenges, especially on how to classify the course and outcome of the disease in ways that may be relevant to analysis of biological factors that might be influenced by genes, The power of the statistical approaches to detect small effects of individual genes in complex disorders such as MS is problematic, and approaches to estimate power must be appropriate for the data. Nonetheless, using contemporary schemes of classification, genetic variants that influence disease course have been found; in fact, a small number have been confirmed to influence disease course in two or more independent studies. This review addresses strategies relevant to identification of disease modifying genes in MS, and summarizes and critically evaluates the cur-rent state of knowledge in this area. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:144 / 159
页数:16
相关论文
共 50 条
  • [21] Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
    Jalkh, Georges
    Abi Nahed, Rachelle
    Macaron, Gabrielle
    Rensel, Mary
    VACCINES, 2021, 9 (01) : 1 - 30
  • [22] Disease-modifying treatments for progressive multiple sclerosis
    Comi, Giancarlo
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1428 - 1436
  • [23] Current Disease-Modifying Treatment of Multiple Sclerosis
    Derwenskus, Joy
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 161 - 175
  • [24] Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom
    Owens, Trudy
    Evangelou, Nikos
    Whynes, David K.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (02) : 315 - 321
  • [25] To stop or not to stop disease modifying therapies in secondary progressive multiple sclerosis, that is the question
    D'Amico, Emanuele
    Ziemssen, Tjalf
    Cottone, Salvatore
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (09) : 847 - 849
  • [26] Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
    Alosaimi, Fahad D.
    AlMulhem, Alaa
    AlShalan, Hanan
    Alqazlan, Mohammad
    Aldaif, Abdulgader
    Kowgier, Matthew
    Balasundaram, Janooshsheya
    Sockalingam, Sanjeev
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 513 - 518
  • [27] Rationale and strategy for the use of disease-modifying therapies in multiple sclerosis.
    Magy, Laurent
    ACTUALITES PHARMACEUTIQUES, 2025, 64 (644): : 29 - 34
  • [28] Identifying copy number variants and genes associated with multiple sclerosis
    Lin, Xin
    Singh, Vikrant
    Yang, Yuanhao
    Blackburn, Nicholas B.
    Motyer, Allan
    McComish, Bennet J.
    Leslie, Stephen
    Broadley, Simon
    Jokubaitis, Vilija
    Kermode, Allan
    Lechner-Scott, Jeanette
    Parnell, Grant P.
    Fabis-Pedrini, Marzena J.
    Scott, Rodney J.
    Kilpatrick, Trevor J.
    Rubio, Justin P.
    Gratten, Jacob
    Taylor, Bruce V.
    Zhou, Yuan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (04) : 10 - 11
  • [29] No association between disease modifying treatment and fatigue in multiple sclerosis
    Broch, Line
    Flemmen, Heidi Oyen
    Simonsen, Cecilia Smith
    Berg-Hansen, Pal
    Ormstad, Heidi
    Brunborg, Cathrine
    Celius, Elisabeth Gulowsen
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [30] Cancer and multiple sclerosis in the era of disease-modifying treatments
    Lebrun, Christine
    Vermersch, Patrick
    Brassat, David
    Defer, Gilles
    Rumbach, Lucien
    Clavelou, Pierre
    Debouverie, Marc
    de Seze, Jerome
    Wiertlevsky, Sandrine
    Heinzlef, Olivier
    Tourbah, Ayman
    Fromont, Agnes
    Frenay, Marc
    JOURNAL OF NEUROLOGY, 2011, 258 (07) : 1304 - 1311